A. P. Dubbewar, B. Pathak, M. Biswas, and G. Malhotra, “Combined use of CA 125 and Inhibin as tumor marker for detection of ovarian cancer in comparison to CA 125 or Inhibin alone”, Int J Reprod Contracept Obstet Gynecol, vol. 6, no. 12, pp. 5313–5316, Nov. 2017.